| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 20.366 | 39.520 | 53.018 | 45.612 | 37.489 | 46.427 | 45.309 |
| Total Income - EUR | - | - | - | 20.385 | 40.038 | 53.371 | 47.411 | 38.084 | 46.515 | 45.311 |
| Total Expenses - EUR | - | - | - | 178 | 1.645 | 1.397 | 3.624 | 5.172 | 13.553 | 21.045 |
| Gross Profit/Loss - EUR | - | - | - | 20.207 | 38.392 | 51.974 | 43.786 | 32.912 | 32.962 | 24.266 |
| Net Profit/Loss - EUR | - | - | - | 19.596 | 37.201 | 50.410 | 42.522 | 32.269 | 27.780 | 20.378 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Olzal Symbiosis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 448 | 64 | 0 | 0 |
| Current Assets | - | - | - | 20.319 | 37.619 | 53.173 | 43.215 | 33.652 | 31.318 | 28.985 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 8.058 | 20.314 | 23.154 | 26.988 | 32.010 | 25.254 | 22.863 |
| Cash | - | - | - | 12.261 | 17.305 | 30.018 | 16.227 | 1.642 | 6.063 | 6.121 |
| Shareholders Funds | - | - | - | 19.639 | 37.251 | 50.459 | 42.571 | 32.318 | 27.829 | 20.426 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 681 | 368 | 712 | 644 | 1.334 | 3.489 | 8.558 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 448 | 64 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Olzal Symbiosis S.r.l.